Chronic neutrophilic leukemia epidemiology and demographics: Difference between revisions
Homa Najafi (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Chronic neutrophilic leukemia}} | {{Chronic neutrophilic leukemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Homa}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
Chronic neutrophilic leukemia is an extremely rare disease. There are almost only 200 patients with CNL worldwide. The exact incidence of CNL is undetermined. | Chronic neutrophilic leukemia is an extremely [[rare]] [[disease]]. There are almost only 200 patients with CNL [[worldwide]]. The exact [[incidence]] of CNL is [[undetermined]]. The [[median age]] at diagnosis is 66.5 years and the [[incidence]] of [[disease]] increases with age. There is no [[racial]] [[predilection]] to CNL and it affects men and women almost equally. | ||
The median age at diagnosis is 66.5 years and the incidence of disease increases with age. There is no racial predilection to CNL and it affects men and women almost equally. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The exact incidence of CNL is undetermined.<ref name="SzuberTefferi2018">{{cite journal|last1=Szuber|first1=Natasha|last2=Tefferi|first2=Ayalew|title=Chronic neutrophilic leukemia: new science and new diagnostic criteria|journal=Blood Cancer Journal|volume=8|issue=2|year=2018|issn=2044-5385|doi=10.1038/s41408-018-0049-8}}</ref> | *The exact [[incidence]] of CNL is undetermined.<ref name="SzuberTefferi2018">{{cite journal|last1=Szuber|first1=Natasha|last2=Tefferi|first2=Ayalew|title=Chronic neutrophilic leukemia: new science and new diagnostic criteria|journal=Blood Cancer Journal|volume=8|issue=2|year=2018|issn=2044-5385|doi=10.1038/s41408-018-0049-8}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
| Line 16: | Line 14: | ||
===Age=== | ===Age=== | ||
*The incidence of CNL increases with age; the median age at diagnosis is 66.5 years. <ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref> | *The [[incidence]] of CNL increases with age; the median age at [[diagnosis]] is 66.5 years. <ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to CNL.<ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref> | *There is no [[racial]] predilection to CNL.<ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref> | ||
===Gender=== | ===Gender=== | ||
| Line 29: | Line 27: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 20:57, 29 July 2020
|
Chronic neutrophilic leukemia Microchapters |
|
Differentiating Chronic neutrophilic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic neutrophilic leukemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Chronic neutrophilic leukemia epidemiology and demographics |
|
FDA on Chronic neutrophilic leukemia epidemiology and demographics |
|
CDC on Chronic neutrophilic leukemia epidemiology and demographics |
|
Chronic neutrophilic leukemia epidemiology and demographics in the news |
|
Blogs on Chronic neutrophilic leukemia epidemiology and demographics |
|
Directions to Hospitals Treating Chronic neutrophilic leukemia |
|
Risk calculators and risk factors for Chronic neutrophilic leukemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
Chronic neutrophilic leukemia is an extremely rare disease. There are almost only 200 patients with CNL worldwide. The exact incidence of CNL is undetermined. The median age at diagnosis is 66.5 years and the incidence of disease increases with age. There is no racial predilection to CNL and it affects men and women almost equally.
Epidemiology and Demographics
Incidence
Prevalence
- There are almost only 200 patients with CNL worldwide.[2]
Age
Race
Gender
- CNL affects men and women equally.[3]
References
- ↑ Szuber, Natasha; Tefferi, Ayalew (2018). "Chronic neutrophilic leukemia: new science and new diagnostic criteria". Blood Cancer Journal. 8 (2). doi:10.1038/s41408-018-0049-8. ISSN 2044-5385.
- ↑ Swerdlow, Steven (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer. ISBN 9789283224310.
- ↑ 3.0 3.1 3.2 Elliott, Michelle A. (2006). "Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined". Best Practice & Research Clinical Haematology. 19 (3): 571–593. doi:10.1016/j.beha.2005.07.012. ISSN 1521-6926.